DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award

<p><strong>Summary:</strong> The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award (TDRA) is to support product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life. Treatment-focused applications should be therapeutic evaluation studies designed to advance new ideas aimed at drug or treatment discovery that are still in the early/preclinical stages of development. Diagnosis-focused applications should propose diagnostic approaches that will be readily integrated into clinical settings. <strong style="color: rgb(0, 176, 80);"><em> </em></strong></p><p><br></p><p><a href="https://cdmrp.health.mil/pubs/press/2026/tbdrppreann" target="_blank">https://cdmrp.health.mil/pubs/press/2026/tbdrppreann</a></p><p><br></p>